CORRA is an investigator-initiated , randomized , multicenter , double-blind , placebo-controlled trial with two treatment arms , starting with 60 mg or 10 mg prednisolone per day , tapered down to 5 mg prednisolone within eight weeks , and one placebo arm , each arm comprising 150 patients .